SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-017960
Filing Date
2020-09-17
Accepted
2020-09-17 14:50:54
Documents
16
Period of Report
2020-09-17
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 36117
2 ex99-1.htm EX-99.1 1008
3 ex99-2.htm EX-99.2 23806
4 ex99-1_001.jpg GRAPHIC 2699856
5 ex99-2_001.jpg GRAPHIC 2784
  Complete submission text file 0001493152-20-017960.txt   3963131

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE vbiv-20200917.xsd EX-101.SCH 3195
7 XBRL LABEL FILE vbiv-20200917_lab.xml EX-101.LAB 34591
8 XBRL PRESENTATION FILE vbiv-20200917_pre.xml EX-101.PRE 22716
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3599
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37769 | Film No.: 201180962
SIC: 2834 Pharmaceutical Preparations